Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
1 hedge funds and large institutions have $0 invested in Pernix Therapeutics Holdings, Inc. in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.
97% less funds holding
Funds holding: 32 → 1 (-31)
97% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 32
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $934K → $0 (-$934K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$218 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$481K |
| 2 |
BlackRock
New York
|
-$96K |
| 3 |
AC
Aisling Capital
New York
|
-$88K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$53K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$38K |
PTX Hedge Fund Activity: Q1 2019 in Review
1 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q1 2019, worth a combined $0 — down 100% from $934K a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of PTX and 1 opened new positions — a net loss of 31 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Simplex Trading, opening a new position worth an estimated $218. The largest seller was Renaissance Technologies, exiting entirely with an estimated $481K sold.
- 1 institutional investor held Pernix Therapeutics Holdings, Inc. (PTX) as of Q1 2019, down from 32 in Q4 2018.
- Funds reported $0 of Pernix Therapeutics Holdings, Inc. stock for Q1 2019, down 100% quarter-over-quarter.
- 1 fund opened new Pernix Therapeutics Holdings, Inc. positions in Q1 2019 and 32 closed out, a net change of -31 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q1 2019 was Simplex Trading, an estimated $218 added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q1 2019 was Renaissance Technologies, an estimated $481K sold.
Based on aggregated 13F filings for Q1 2019.